2024-04-012025-03-312025-03-31false07135271VICARAGE VETERINARY CENTRE LIMITED2025-12-2475000falseiso4217:GBPxbrli:pure071352712024-03-31071352712025-03-31071352712024-04-012025-03-31071352712023-03-31071352712024-03-31071352712023-04-012024-03-3107135271bus:SmallEntities2024-04-012025-03-3107135271bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107135271bus:FullAccounts2024-04-012025-03-3107135271bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107135271core:WithinOneYear2025-03-3107135271core:AfterOneYear2025-03-3107135271core:WithinOneYear2024-03-3107135271core:AfterOneYear2024-03-3107135271core:ShareCapital2025-03-3107135271core:SharePremium2025-03-3107135271core:RevaluationReserve2025-03-3107135271core:OtherReservesSubtotal2025-03-3107135271core:RetainedEarningsAccumulatedLosses2025-03-3107135271core:ShareCapital2024-03-3107135271core:SharePremium2024-03-3107135271core:RevaluationReserve2024-03-3107135271core:OtherReservesSubtotal2024-03-3107135271core:RetainedEarningsAccumulatedLosses2024-03-3107135271core:LandBuildings2025-03-3107135271core:PlantMachinery2025-03-3107135271core:Vehicles2025-03-3107135271core:FurnitureFittings2025-03-3107135271core:OfficeEquipment2025-03-3107135271core:NetGoodwill2025-03-3107135271core:IntangibleAssetsOtherThanGoodwill2025-03-3107135271core:ListedExchangeTraded2025-03-3107135271core:UnlistedNon-exchangeTraded2025-03-3107135271core:LandBuildings2024-03-3107135271core:PlantMachinery2024-03-3107135271core:Vehicles2024-03-3107135271core:FurnitureFittings2024-03-3107135271core:OfficeEquipment2024-03-3107135271core:NetGoodwill2024-03-3107135271core:IntangibleAssetsOtherThanGoodwill2024-03-3107135271core:ListedExchangeTraded2024-03-3107135271core:UnlistedNon-exchangeTraded2024-03-3107135271core:LandBuildings2024-04-012025-03-3107135271core:PlantMachinery2024-04-012025-03-3107135271core:Vehicles2024-04-012025-03-3107135271core:FurnitureFittings2024-04-012025-03-3107135271core:OfficeEquipment2024-04-012025-03-3107135271core:NetGoodwill2024-04-012025-03-3107135271core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107135271core:ListedExchangeTraded2024-04-012025-03-3107135271core:UnlistedNon-exchangeTraded2024-04-012025-03-3107135271core:MoreThanFiveYears2024-04-012025-03-3107135271core:Non-currentFinancialInstruments2025-03-3107135271core:Non-currentFinancialInstruments2024-03-3107135271dpl:CostSales2024-04-012025-03-3107135271dpl:DistributionCosts2024-04-012025-03-3107135271core:LandBuildings2024-04-012025-03-3107135271core:PlantMachinery2024-04-012025-03-3107135271core:Vehicles2024-04-012025-03-3107135271core:FurnitureFittings2024-04-012025-03-3107135271core:OfficeEquipment2024-04-012025-03-3107135271dpl:AdministrativeExpenses2024-04-012025-03-3107135271core:NetGoodwill2024-04-012025-03-3107135271core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107135271dpl:GroupUndertakings2024-04-012025-03-3107135271dpl:ParticipatingInterests2024-04-012025-03-3107135271dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107135271core:ListedExchangeTraded2024-04-012025-03-3107135271dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107135271core:UnlistedNon-exchangeTraded2024-04-012025-03-3107135271dpl:CostSales2023-04-012024-03-3107135271dpl:DistributionCosts2023-04-012024-03-3107135271core:LandBuildings2023-04-012024-03-3107135271core:PlantMachinery2023-04-012024-03-3107135271core:Vehicles2023-04-012024-03-3107135271core:FurnitureFittings2023-04-012024-03-3107135271core:OfficeEquipment2023-04-012024-03-3107135271dpl:AdministrativeExpenses2023-04-012024-03-3107135271core:NetGoodwill2023-04-012024-03-3107135271core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107135271dpl:GroupUndertakings2023-04-012024-03-3107135271dpl:ParticipatingInterests2023-04-012024-03-3107135271dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107135271core:ListedExchangeTraded2023-04-012024-03-3107135271dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107135271core:UnlistedNon-exchangeTraded2023-04-012024-03-3107135271core:NetGoodwill2025-03-3107135271core:IntangibleAssetsOtherThanGoodwill2025-03-3107135271core:LandBuildings2025-03-3107135271core:PlantMachinery2025-03-3107135271core:Vehicles2025-03-3107135271core:FurnitureFittings2025-03-3107135271core:OfficeEquipment2025-03-3107135271core:AfterOneYear2025-03-3107135271core:WithinOneYear2025-03-3107135271core:ListedExchangeTraded2025-03-3107135271core:UnlistedNon-exchangeTraded2025-03-3107135271core:ShareCapital2025-03-3107135271core:SharePremium2025-03-3107135271core:RevaluationReserve2025-03-3107135271core:OtherReservesSubtotal2025-03-3107135271core:RetainedEarningsAccumulatedLosses2025-03-3107135271core:NetGoodwill2024-03-3107135271core:IntangibleAssetsOtherThanGoodwill2024-03-3107135271core:LandBuildings2024-03-3107135271core:PlantMachinery2024-03-3107135271core:Vehicles2024-03-3107135271core:FurnitureFittings2024-03-3107135271core:OfficeEquipment2024-03-3107135271core:AfterOneYear2024-03-3107135271core:WithinOneYear2024-03-3107135271core:ListedExchangeTraded2024-03-3107135271core:UnlistedNon-exchangeTraded2024-03-3107135271core:ShareCapital2024-03-3107135271core:SharePremium2024-03-3107135271core:RevaluationReserve2024-03-3107135271core:OtherReservesSubtotal2024-03-3107135271core:RetainedEarningsAccumulatedLosses2024-03-3107135271core:NetGoodwill2023-03-3107135271core:IntangibleAssetsOtherThanGoodwill2023-03-3107135271core:LandBuildings2023-03-3107135271core:PlantMachinery2023-03-3107135271core:Vehicles2023-03-3107135271core:FurnitureFittings2023-03-3107135271core:OfficeEquipment2023-03-3107135271core:AfterOneYear2023-03-3107135271core:WithinOneYear2023-03-3107135271core:ListedExchangeTraded2023-03-3107135271core:UnlistedNon-exchangeTraded2023-03-3107135271core:ShareCapital2023-03-3107135271core:SharePremium2023-03-3107135271core:RevaluationReserve2023-03-3107135271core:OtherReservesSubtotal2023-03-3107135271core:RetainedEarningsAccumulatedLosses2023-03-3107135271core:AfterOneYear2024-04-012025-03-3107135271core:WithinOneYear2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107135271core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107135271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107135271core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107135271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107135271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107135271bus:Director12024-04-012025-03-3107135271bus:Director22024-04-012025-03-31

VICARAGE VETERINARY CENTRE LIMITED

Registered Number
07135271
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

VICARAGE VETERINARY CENTRE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

CHARNOCK, Jasmine Lily Marina
SACKX, Annick Irma, Dr

Registered Address

52 Church Road
Saxilby
Lincoln
LN1 2HJ

Registered Number

07135271 (England and Wales)
VICARAGE VETERINARY CENTRE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets335,59342,712
Tangible assets477,00058,147
112,593100,859
Current assets
Stocks537,22633,440
Debtors621,39322,327
Cash at bank and on hand45,619139,553
104,238195,320
Creditors amounts falling due within one year7(99,164)(125,542)
Net current assets (liabilities)5,07469,778
Total assets less current liabilities117,667170,637
Provisions for liabilities8(14,630)(11,339)
Net assets103,037159,298
Capital and reserves
Called up share capital22
Profit and loss account103,035159,296
Shareholders' funds103,037159,298
The financial statements were approved and authorised for issue by the Board of Directors on 24 December 2025, and are signed on its behalf by:
CHARNOCK, Jasmine Lily Marina
Director
Registered Company No. 07135271
VICARAGE VETERINARY CENTRE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery15
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year1816
3.Intangible assets
Positive goodwill is capitalised, classified as an asset on the balance sheet and amortised on a straight line basis over its useful economic life of 20 years. It is reviewed for impairment at the end of the first full financial year following the acquisition and in other periods if events or changes in circumstances indicate that the carrying value may not be recoverable.

Goodwill

Total

££
Cost or valuation
At 01 April 24142,370142,370
At 31 March 25142,370142,370
Amortisation and impairment
At 01 April 2499,65899,658
Charge for year7,1197,119
At 31 March 25106,777106,777
Net book value
At 31 March 2535,59335,593
At 31 March 2442,71242,712
4.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 April 24140,944140,944
Additions30,76230,762
At 31 March 25171,706171,706
Depreciation and impairment
At 01 April 2482,79782,797
Charge for year11,90911,909
At 31 March 2594,70694,706
Net book value
At 31 March 2577,00077,000
At 31 March 2458,14758,147
5.Stocks

2025

2024

££
Finished goods37,22633,440
Total37,22633,440
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables18,84920,391
Prepayments and accrued income2,5441,936
Total21,39322,327
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables22,96735,169
Taxation and social security42,96459,844
Other creditors30,47327,769
Accrued liabilities and deferred income2,7602,760
Total99,164125,542
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)14,63011,339
Total14,63011,339
9.Related party transactions
At balance sheet date balance of Director Loan Account is £27,316 (2024: £25,091).